NCT03733691 Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients Status TERMINATED Phase PHASE2
NCT03729609 Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma" Status COMPLETED Phase N/A
NCT03727139 Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety" Status COMPLETED Phase N/A
NCT03724929 Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis Status TERMINATED Phase NA
NCT03720041 Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma Status UNKNOWN Phase PHASE3
NCT03710486 A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants Status COMPLETED Phase N/A
NCT03709576 Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML Status TERMINATED Phase PHASE2
NCT03706469 A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT03706456 Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease Status COMPLETED Phase PHASE3
NCT03694275 A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY) Status COMPLETED Phase PHASE2
NCT03683277 IPD in RRMM Characterized with Genomic Abnormalities of Adverse Prognostic Status TERMINATED Phase PHASE2
NCT03668249 A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD) Status COMPLETED Phase N/A
NCT03666858 A Study to Describe Pain Intensity, Pain Relief and Safety of Neosaldina in the Treatment of Tension-type Headaches (TTH) in Healthy Participants Status COMPLETED Phase N/A
NCT03650452 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies Status COMPLETED Phase PHASE2
NCT03648372 A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System Status TERMINATED Phase PHASE1/PHASE2
NCT03635073 A Study of Soticlestat in Adults and Children With Rare Epilepsies Status TERMINATED Phase PHASE2